|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.47 INR | -2.13% |
|
-2.13% | -17.97% |
The Board of Directors of Bafna Pharmaceuticals Limited in their meeting held on May 29, 2024 approved the appointment of Mr. A. Mohanachandran, as the Company Secretary & Compliance Officer of the Company with effect from May 29, 2024. Mr. Mohanachandran, is a qualified CompanySecretary and an Associate Member of Institute of Company Secretaries of India with ICSI Membership No. A65827.
He has 4 years of Post-Qualification Experience.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.97% | 21.39M | |
| +21.14% | 43.59B | |
| +28.00% | 22.54B | |
| +21.43% | 15.73B | |
| +18.67% | 14.33B | |
| +56.41% | 12.75B | |
| -0.05% | 6.79B | |
| -12.70% | 6.48B | |
| -8.87% | 5.73B | |
| +15.72% | 5.67B |
BAFNA PHARMACEUTICALS LIMITED 
